Parish et al., 2016 - Google Patents
Toward a more evidence-based nosology and nomenclature for female sexual dysfunctions—part IIParish et al., 2016
View PDF- Document ID
- 10241966121868384706
- Author
- Parish S
- Goldstein A
- Goldstein S
- Goldstein I
- Pfaus J
- Clayton A
- Giraldi A
- Simon J
- Althof S
- Bachmann G
- Komisaruk B
- Levin R
- Spadt S
- Kingsberg S
- Perelman M
- Waldinger M
- Whipple B
- Publication year
- Publication venue
- The journal of sexual medicine
External Links
Snippet
ABSTRACT Introduction Current Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) definitions of sexual dysfunction do not identify all sexual problems experienced clinically by women and are not necessarily applicable for biologic or …
- 230000001568 sexual 0 title abstract description 174
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times; Devices for evaluating the psychological state
- A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Parish et al. | Toward a more evidence-based nosology and nomenclature for female sexual dysfunctions—part II | |
Brotto et al. | Women’s sexual desire and arousal disorders | |
Rogers et al. | An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction | |
Simon et al. | Sexual well-being after menopause: an international menopause society white paper | |
Kingsberg et al. | Female sexual dysfunction—medical and psychological treatments, committee 14 | |
Levin et al. | The physiology of female sexual function and the pathophysiology of female sexual dysfunction (Committee 13A) | |
Graham | The DSM diagnostic criteria for female orgasmic disorder | |
Nappi et al. | Clinical biologic pathophysiologies of women's sexual dysfunction | |
Basson et al. | Assessment and management of women's sexual dysfunctions: problematic desire and arousal | |
Klein et al. | Continuing medical education: sexual functioning in transsexuals following hormone therapy and genital surgery: a review (CME) | |
Weijmar Schultz et al. | Women's sexual pain and its management | |
Kingsberg et al. | Hypoactive sexual desire in women | |
Meston et al. | Sexual dysfunctions in women | |
Laan et al. | Genital responsiveness in healthy women with and without sexual arousal disorder | |
Nowosielski et al. | Diabetes mellitus and sexuality—does it really matter? | |
IsHak et al. | Disorders of orgasm in women: A literature review of etiology and current treatments | |
Kingsberg et al. | Female sexual disorders: assessment, diagnosis, and treatment | |
Caruso et al. | Sexuality in menopausal women | |
Battaglia et al. | PCOS, sexuality, and clitoral vascularisation: a pilot study | |
Steinke | Sexual dysfunction in women with cardiovascular disease: what do we know? | |
Fooladi et al. | An update on the pharmacological management of female sexual dysfunction | |
Calogero et al. | Lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction: from physiology to clinical aspects | |
Cipriani et al. | Effects of testosterone treatment on clitoral haemodynamics in women with sexual dysfunction | |
Morotti et al. | Clitoral changes, sexuality, and body image during the menstrual cycle: a pilot study | |
Basson et al. | Women’s sexual desire and arousal disorders and sexual pain |